Could baricitinib be a safe and effective therapeutic alternative for incoercible pruritus in patients with dermatitis herpetiformis?
International Journal of Dermatology · 2024-01 · 63 (1)
DOI: 10.1111/ijd.16878 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 11.10.2023. Verfasst von Alvaro Prados-Carmona und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain. Hauptthemen laut MEDLINE: Dermatitis Herpetiformis, Azetidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
- Department of Contact Eczema and Immunoallergic Diseases, Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
ORCID-Profile: Alvaro Prados-Carmona, Francisco J Navarro-Triviño
Zitieren
APA
Prados-Carmona, A., Ruiz-Villaverde, R., & Navarro-Triviño, F. J. (2024). Could baricitinib be a safe and effective therapeutic alternative for incoercible pruritus in patients with dermatitis herpetiformis?. International Journal of Dermatology, 63(1). https://doi.org/10.1111/ijd.16878
Vancouver
Prados-Carmona A, Ruiz-Villaverde R, Navarro-Triviño FJ. Could baricitinib be a safe and effective therapeutic alternative for incoercible pruritus in patients with dermatitis herpetiformis?. International Journal of Dermatology. 2024;63(1). doi:10.1111/ijd.16878
BibTeX
@article{PradosCarmona2024,
author = {Prados-Carmona, Alvaro and Ruiz-Villaverde, Ricardo and Navarro-Triviño, Francisco J},
title = {Could baricitinib be a safe and effective therapeutic alternative for incoercible pruritus in patients with dermatitis herpetiformis?},
journal = {International Journal of Dermatology},
year = {2024},
volume = {63},
number = {1},
doi = {10.1111/ijd.16878}
}
EUVIMED